|
An open label, randomised cross-over bioavailability study of oral paclitaxel (oraxol) compared to intravenous paclitaxel 80mg/m2. |
|
Christopher G. C. A. Jackson |
Employment - Mercy Cancer Care |
Leadership - Mercy Cancer Care |
Stock and Other Ownership Interests - Mercy Cancer Care |
Research Funding - Kinex (Inst) |
Travel, Accommodations, Expenses - MSD Oncology |
Other Relationship - Cancer Society of New Zealand |
|
Katherine Francis Bayston |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
|
|
|
Stock and Other Ownership Interests - Lilly; Merck; Vertex |
|
|
|
Stock and Other Ownership Interests - DemeRx; Kinex |
Consulting or Advisory Role - Kinex |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |